Alan Fine on Advances in stem cell therapy
Alan Fine, Professor of Medicine, Director Stem Cell Biology Program, Boston University Alan Fine spoke at the Expert Exchange Roundtable on Pushing the boundaries of longevity, 9 September 2011, sSwissnex Boston, Cambridge, Massachusetts, USAFrom:swissretvViews:12 0ratingsTime:01:18:35More inEducation

Excerpt from:
Alan Fine on Advances in stem cell therapy - Video

Live Cell Therapy | Stem Cell Malaysia
stemcellmalaysia.com Live cell therapy is one form of stem cell therapy under the hierarchy of cell therapy, which is under regenerative medicine. Live cell therapy was made popular since 1931 by Dr Paul Niehans, who pioneered the therapy using injection. Oral or injection live cell therapy is far more superior than surgical implantation due to several advantages. Today, live cell therapy has been applied to disease treatment, beauty and health rejuvenation. For more information on stem cell therapy, please visit Stem Cell Malaysia at stemcellmalaysia.comFrom:stemcells2012Views:172 10ratingsTime:12:14More inScience Technology

See the original post:
Live Cell Therapy | Stem Cell Malaysia - Video

123Triad : fatgraftforumcom
123Triad is proud to design website for http://www.fatgraftforum.com Autologous fat grafting is rapidly becoming the standard in the field of Plastic Surgery and the demand for knowledge and advances in fat grafting have significantly increased. The International Fat Grafting Forum will present renowned physicians from all over the world to promote the advancement of fat grafting technology and techniques including the ongoing debate on stem cell therapy.From:123triadorgViews:2 0ratingsTime:00:36More inScience Technology

The rest is here:
123Triad : fatgraftforumcom - Video

MissouriCuresEvents_Oct2012_Dr.MarieCsete
"The stem cell therapy race: roadblocks to the finish line", as presented by Dr. Marie Csete at The Danforth Center on behalf of Missouri Cures Education Foundation #39;s Speaker Series in October, 2012.From:MissouriCuresEventsViews:1 0ratingsTime:51:36More inNonprofits Activism

Read more:
MissouriCuresEvents_Oct2012_Dr.MarieCsete - Video

Stem Cell Therapy (IMC)
New Project 40From:OmarGonzalezMDViews:0 0ratingsTime:01:48More inScience Technology

Read more here:
Stem Cell Therapy (IMC) - Video

Sources Of Stem Cells | Stem Cell Malaysia
stemcellmalaysia.com Sources of stem cells play a critical role in determining the outcome of stem cell therapy. Without a clear idea of the sources of stem cells, it is risky to be engaged in any form of stem cells treatment. The sources of stem cells include the type of animals, the location of the animals, and the parts of the animal. For more information on sources of stem cells, please visit Stem Cell Malaysia at stemcellmalaysia.comFrom:stemcells2012Views:207 9ratingsTime:04:13More inScience Technology

Read more:
Sources Of Stem Cells | Stem Cell Malaysia - Video

Robert Toves Testimonial (Parkinson #39;s Disease) Stem Cell Therapy
Robert Toves is a patient at Integra Medical Center, Mr.Toves suffers of Parkinson #39;s disease and has come to try Dr.Gonzalez method of stem cell therapy, just less than an hour after the stem cell therapy great results seem to show.From:OmarGonzalezMDViews:1 0ratingsTime:05:58More inScience Technology

Read more here:
Robert Toves Testimonial (Parkinson's Disease) Stem Cell Therapy - Video

Stem Cell Therapy (Cerebral Palsy)
New Project 43From:OmarGonzalezMDViews:3 0ratingsTime:02:07More inScience Technology

Read more here:
Stem Cell Therapy (Cerebral Palsy) - Video

Stem Cell Therapy - Let Your Own Stem Cells Make Wrinkles Virtually Disappear! Free postage
Stem Cell Therapy - Let Your Own Stem Cells Make Wrinkles Virtually Disappear!From:Deals2uTVViews:0 0ratingsTime:02:01More inHowto Style

See the rest here:
Stem Cell Therapy - Let Your Own Stem Cells Make Wrinkles Virtually Disappear! Free postage - Video

Biotechnology simply means to develop or to make useful products with the help of using living systems. Over the years mankind has used biotechnology in several sectors like agriculture, food production and medicine. There are several sectors in which biotechnology can affect severely.

Biotech for human enhancement is the most profitable industry in the 21st century. Careers are influenced by genetic heritage. It is said that by 2020 people will be able to decipher human genome

Which is nothing but the blueprint of our DNA? One of the trends is towards the genetic solutions to the ills. There are several newly discovered drugs will save countless no of lives. These drugs can also eliminate many diseases. A lot of research works have been done on the recent trends for biotechnology. Research output continues to shift to ASIA. The current trends in biotechnology are its association with pharmacy. It is said that within few more years people will be able to turn on or turn off certain genes which can influence on health and performance. People can eliminate unwanted characteristics by using altered genes from their babies. People can also enhance their babies’ capabilities by using the same method. There is different classification of biotechnology having different application of each. Like white or industrial biotechnology helps in the production of chemical base materials and end products. Red biotechnology means development of new medical drugs. Biotechnology is the driving factor behind many applications in medicine. Green or Plant biotechnology is used in production of plants which are renewable recourses. Biotechnology is integrated use of many biological technologies. It also has trends in horticulture. One of the emerging trends in Biotechnology have been observed and noted in recent years. One such trend is the trend in partnering and acquisition of deals. This is applicable to the business perspective towards the delivery and realization of more up to date by products. So basically there are a lot of sectors in which biotechnology can affect. But one of the most suitable choices is pharmaceutical sector. People are focusing more and more now days on the use of biotechnological products. There are a lot of independent biotechnology companies which deals directly with these biotechnological products. Biotechnology is used to develop commercial product also. Biotechnology becomes central priority of the government’s research policy to ensure a high standing of biosciences and to develop newer innovation techniques. At present there are 25 different initiatives to financially support universities, research institutes. They all are working like a chain having same common objectives. There is a healthy competition in between the companies which in turn increases the level of biotechnological products. The key element of this initiative is Biopharma competition. So it depends on the people how they utilize biotechnological products for their better interest.

Biotechnology is a technology which never goes opposite to the nature.

We have to improve the biotechnology with the help of nature. Now a days lots of course are based on Biotechnology in various colleges all over the world. It becomes popular to all the students also.

Source:
http://www.biotechblog.org/entry/top-trends-biotechnology/

swissinfo.ch

Billionaires push for Geneva research centre swissinfo.ch At a press conference in Bern on Wednesday, the consortium, which includes the Federal Institute of Technology in Lausanne (EPFL) and Geneva University, said the centre would focus on research in the areas of health, biotechnology and life sciences.

Source:
http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNFWCC10_wOgk-P06uWd9W7IEw90lg&url=http://www.swissinfo.ch/eng/science_technology/Billionaires_push_for_Geneva_research_centre.html?cid%3D34116782

University of Delaware

NASA funds astrobiology research by Delaware Biotechnology Institute scientist University of Delaware 9:02 a.m., Dec. 3, 2012--Does life exist anywhere else in the universe? That's the type of broad but poignant question NASA likes to ask, according to Chandran Sabanayagam, associate scientist in the Bioimaging Center at the Delaware Biotechnology ... and more »

Source:
http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNFERLNhu91w5KszujZY2zU2jjwDRA&url=http://www.udel.edu/udaily/2013/dec/dbi-nasa-astrobiology-120312.html

UAB News

UAB researcher named AAAS Fellow UAB News N. Rama Krishna, Ph.D., professor in the UAB Department of Biochemistry and Molecular Genetics, has been named as a fellow of the American Association for the Advancement of Science (AAAS) by his peers in the organization. Krishna also is the director ... UMass Medical School faculty elected to the American Association for the ...Phys.Org (press release) all 45 news articles »

Source:
http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNGX4pMkXktXEGFZDvFV_SwSKFe_MQ&url=http://www.uab.edu/news/briefs/item/2956-uab-researcher-named-aaas-fellow

SB Nation

Chicago Bears hit the jackpot with WR Brandon Marshall SB Nation You don't need to sort through reams of data or major in molecular genetics to have a working knowledge of just how pathetic Chicago Bears quarterbacks have been since, oh, the dawn of time. The franchise's most revered and accomplished passer to date ... and more »

Source:
http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNH5PXI0N9CVy3Osj2fI26xIU6OsQA&url=http://chicago.sbnation.com/chicago-bears/2012/12/7/3740098/chicago-bears-brandon-marshall-jay-cutler-stats

Merced Sun-Star

Frustration over lack of valley fever drugs Merced Sun-Star It's "a clear, unmet clinical need," said Dr. Joseph Heitman, chairman of Duke University's Department of Molecular Genetics and Microbiology. Even when treatments do fight off valley fever, they can cause significant side effects. Pregnant women can't ... and more »

Source:
http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNF9jVy2ZY3TwrPblfzNwEe4QPLGkQ&url=http://www.mercedsunstar.com/2012/12/08/2694456/frustration-over-lack-of-valley.html

Toledo Blade

2002 Buckeyes: Director Krenzel Toledo Blade At OSU, the quarterback conducted cancer research, balanced the title run with a graduate-level course load of Molecular Genetics 608, Molecular Genetics 701, and Microbiology, and graduated with a 3.75 GPA. If the fall of 2002 taught him anything, it ...

Source:
http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNFPF38Y3m3n1SYafkKGa2wn-Yp5VA&url=http://www.toledoblade.com/Ohio-State/2012/11/11/Ohio-State-QB-Krenzel-It-was-meant-to-be.html

Newsday

Brooklyn science club mixes beer with research talk Newsday The molecular genetics. The marine biology. The neuroscience. Those are the topics of the Secret Science Club, a monthly event that brings people to hear scientists and researchers talking about their work, accompanied by signature cocktails like the ... Secret science club mixes knowledge with cocktailsPallTimes.com all 25 news articles »

Source:
http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNHavX3RCZu2VX065xGAK7a1kZdpeA&url=http://www.newsday.com/news/new-york/brooklyn-science-club-mixes-beer-with-research-talk-1.4256956

Jonathan Thomas CIRM Photo

Jonathan Thomas, the Los Angeles bond
financier who is chairman of the $3 billion California stem cell agency, has
weighed in at more length on the sweeping recommendations from the
Institute of Medicine for changes at the agency.

Source:
http://feedproxy.google.com/~r/blogspot/uqpFc/~3/HmbrFtBzcs4/stem-cell-agency-chairman-says-iom.html

The Institute of Medicine's
recommendations for major changes at the California stem cell agency
today received generally high marks from independent observers and
critics.

“The institute’s recommendations
for much-needed changes to CIRM’s governance structure to provide
greater efficiency, clarity and accountability reinforce the
recommendations the Little Hoover Commission made in 2009."

“Then and now, the Commission’s
recommendations are aimed at improving CIRM’s ability to meet its
goals for the good of all who can benefit from stem cell research,
and to ensure that California taxpayers’ dollars are put to their
most efficient use to that end.”

“The IOM Committee and its staff have
done an impressive job.  The report recognizes the scientific
value and achievements of the CIRM and, at the same time, makes
cogent recommendations that, if taken seriously, will further improve
the quality and the public credibility of the Institute. The
committee and staff deserve the thanks of the scientific community
and all California citizens for their careful and thoughtful work.” 

“It's long past time to make the
changes the report calls for, but given the spin the agency put on
its response -- saying the report praises the 'agency as a bold
innovation' -- shows it's business as usual. This sort of behavior
will only ensure that CIRM doesn't get another round of public
funding,” 

“Given the agency’s shortcomings
and the state’s budgetary problems, it would be wrong to ask
Californians to give it more public money. If the agency acquires new
funds from industry sources or venture firms, it must recognize that
it has ongoing obligations to the people of California.” 

 “CIRM has not
responded in a meaningful way to many previous public interest
suggestions or to independent reviews, including the one in 2009 by
the state’s Little Hoover Commission. We hope the agency will not
continue that pattern.” 

Source:
http://feedproxy.google.com/~r/blogspot/uqpFc/~3/yyZ0TAisMZQ/iom-proposals-for-overhaul-at-cirm-win.html

Here is the full text or the essential
elements of comments sought by the California Stem Cell Report on the
Institute of Medicine report that recommended sweeping changes at the
California stem cell agency. Consumer Watchdog and the Center for
Genetics and Society put their comments in the form of news releases,
which contained redundant material.

“CIRM initiated the Institute of
Medicine review, which is to its credit.  The Institute of
Medicine took a scrupulous and rigorous approach to its review of the
California Institute of Regenerative Medicine and in its report,
notes CIRM’s many achievements and accomplishments.

“The Institute’s recommendations
for much-needed changes to CIRM’s governance structure to provide
greater efficiency, clarity and accountability reinforce the
recommendations the Little Hoover Commission made in 2009. The
institute graciously acknowledged the commission’s work, which
clearly is as relevant now as it was in 2009.

“Then and now, the Commission’s
recommendations are aimed at improving CIRM’s ability to meet its
goals for the good of all who can benefit from stem cell research,
and to ensure that California taxpayers’ dollars are put to their
most efficient use to that end.”

“Consumer Watchdog Thursday welcomed
a report from the prestigious Institute of Medicine (IOM) calling for
sweeping reforms in governance at California’s stem cell agency and
an end to the board’s built-in conflicts of interest. 

“The report said that 'far too many
board members represent organizations' that receive funding or
benefit from the stem cell agency. The IOM said that the board’s
oversight function should be separated from the day-to-day management
of the California Institute for Regenerative Medicine (CIRM). 

“'The IOM's critical report echoes
what every independent evaluator has said in the past,' said John
M. Simpson, Consumer Watchdog’s Stem Cell Project director.
'As we have repeated from the beginning, CIRM suffers from built-in
conflicts of interest and needs to separate the board's oversight
function from day-to-day management.'

“'It's long past time to make the
changes the report calls for, but given the spin the agency put on
its response -- saying the report praises the 'agency as a bold
innovation' -- shows it's business as usual. This sort of behavior
will only ensure that CIRM doesn't get another round of public
funding,' Simpson said.”

“The Center for Genetics and Society,
a nonprofit policy research and advocacy organization, welcomed the
report on the California stem cell agency released today by the
Institute of Medicine and called for stronger protections for  the interests of Californians as
the agency continues its disbursement of public funds.

“CIRM is nearing the end of the
billions of dollars of public funding allocated to it in
2004. The agency is currently considering how to extend
its operations after the money runs out. CGS Associate Executive
Director Marcy Darnovskysaid, “Given the agency’s
shortcomings and the state’s budgetary problems, it would be wrong
to ask Californians to give it more public money. If the agency
acquires new funds from industry sources or venture firms, it must
recognize that it has ongoing obligations to the people of
California.”

“She continued, 'CIRM has not
responded in a meaningful way to many previous public interest
suggestions or to independent reviews, including the one in 2008 by
the state’s Little Hoover Commission. We hope the agency will not
continue that pattern.' 

“'Today’s report from the IOM
reaffirms the significance of the conflicts of interest and
structural flaws that were built into the stem cell program from the
beginning, and that continue to threaten its credibility and
effectiveness. These are serious problems that the Center for
Genetics and Society and other public interest voices pointed out
even before the agency was approved by the 2004 ballot measure on
which backers spent some $35 million. 

“'Many aspects of these early
concerns remain directly relevant,' Darnovsky said. 'There is
still no way for elected officials to provide oversight because the
measure that created CIRM requires a 70% vote by both houses – more
than a supermajority. The agency’s governing board is still tainted
by its built-in conflicts of interest, and still includes no
representation of the public beyond disease advocates. Members of the
agency’s powerful Working Groups, including the one that reviews
grant applications, are still not required to publicly disclose their
individual financial interests.'”

Source:
http://feedproxy.google.com/~r/blogspot/uqpFc/~3/iu4DrhoewYo/text-of-comments-reacting-to-iom-report.html